Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Diatron MI and Medicon Hellas Sign Exclusive Supply Agreement

By LabMedica International staff writers
Posted on 14 Oct 2013
Diatron MI Plc (Budapest, Hungary) and Medicon Hellas SA (Gerakas, Greece) signed an exclusive supply agreement for an extensive range of high quality clinical chemistry reagents for use on the Diatron Pictus range of clinical chemistry analyzers in all international markets except the USA.

All reagents will be manufactured by Medicon Hellas, exclusively for Diatron and have been specifically designed with the Diatron analyzers in mind, so the combination of analyzer and reagents allows customers to employ features and benefits that are only normally possible on high cost clinical chemistry systems. More...
The reagent range will initially consist of 60 test parameters (substrates, enzymes, electrolytes, and specific proteins), which have been developed to meet the needs and demands of today’s modern clinical chemistry laboratory to have precision, linearity, sensitivity, on-board stability, and calibration stability.

Diatron will be exhibiting two new, bench top analyzers at Medica, Dusseldorf (November 20–23, 2013). The new version of the established Abacus 3CT hematology analyzer has been enhanced to make it even easier to use. In addition, Diatron will also be previewing a prototype version of the brand new Pictus 500 clinical chemistry analyzer.

“ We are excited by the new collaboration with Medicon as it will allow us to mutually grow our clinical chemistry business with our global distributor partners and to demonstrate to end-users our commitment to provide them with the full package—a cost effective system (analyzer & reagent) with complete support,“ said Ronald Backes, vice president of International Business- Diatron MI Plc.

“Medicon is delighted to enter into this agreement with Diatron, rewarding the time and effort we have put into developing specific reagents and tests for the Pictus analyzers. We are pleased that customers around the world will now be able to benefit from what Greek laboratories have experienced with the analyzer/reagent combination,” commented Sakis Mitropoulos, director, customer services, Medicon Hellas SA.

Related Links:

Diatron MI
Medicon Hellas



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.